Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)
- Eberhardt, Wilfried Ernst Erich
- Pöttgen, Christoph
- Gauler, Thomas Christoph
- Friedel, Godehard
- Veit, Stefanie
- Heinrich, Vanessa
- Welter, Stefan
- Budach, Wilfried
- Spengler, Werner
- Kimmich, Martin
- Fischer, Berthold
- Schmidberger, Heinz
- De Ruysscher, Dirk
- Belka, Claus
- Cordes, Sebastian
- Hepp, Rodrigo
- Lütke-Brintrup, Diana
- Lehmann, Nils
- Schuler, Martin
- Jöckel, Karl-Heinz
- Stamatis, Georgios
- Stuschke, Martin
Publication date
December 2015
DOI Publisher
Grune & Stratton ISSN
0732-183X Journal
0732-183xAbstract
Concurrent chemoradiotherapy with or without surgery are options for stage IIIA(N2) non-small-cell lung cancer. Our previous phase II study had shown the efficacy of induction chemotherapy followed by chemoradiotherapy and surgery in patients with IIIA(N2) disease and with selected IIIB disease. Here, we compared surgery with definitive chemoradiotherapy in resectable stage III disease after induction.status: publishe
Add to ORKG